{"id":"https://openalex.org/W2423919700","doi":null,"title":"[The plasma prolactin level under fluphenazine treatment (author's transl)].","display_name":"[The plasma prolactin level under fluphenazine treatment (author's transl)].","publication_year":1980,"publication_date":"1980-09-15","ids":{"openalex":"https://openalex.org/W2423919700","mag":"2423919700","pmid":"https://pubmed.ncbi.nlm.nih.gov/7456470"},"language":"de","primary_location":{"id":"pmid:7456470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7456470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wiener medizinische Wochenschrift (1946)","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001658900","display_name":"Hartmann Hinterhuber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Hinterhuber","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111677538","display_name":"T Platz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Platz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"S Schwarz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Schwarz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34957108,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"130","issue":"17","first_page":"566","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.8999999761581421},{"id":"https://openalex.org/keywords/plasma-prolactin","display_name":"plasma prolactin","score":0.9120000004768372},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.746999979019165},{"id":"https://openalex.org/keywords/dopamine-receptor-blockade","display_name":"dopamine receptor blockade","score":0.8569999933242798},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6790000200271606},{"id":"https://openalex.org/keywords/acute-psychosis","display_name":"acute psychosis","score":0.6320000290870667},{"id":"https://openalex.org/keywords/fluphenazine-decanoate","display_name":"fluphenazine decanoate","score":0.906000018119812},{"id":"https://openalex.org/keywords/electroconvulsive-therapy","display_name":"electroconvulsive therapy","score":0.9850000143051147}],"concepts":[{"id":"https://openalex.org/C2776978879","wikidata":"https://www.wikidata.org/wiki/Q58376","display_name":"Fluphenazine","level":4,"score":0.916060209274292},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.9021586179733276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.791546642780304},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6192691326141357},{"id":"https://openalex.org/C3017575891","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma levels","level":2,"score":0.5276604890823364},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47739261388778687},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4702153503894806},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4572888910770416},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4399743378162384},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4218555688858032},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.2875061631202698},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.23363754153251648},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2135307490825653}],"mesh":[{"descriptor_ui":"D005476","descriptor_name":"Fluphenazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007263","descriptor_name":"Infusions, Parenteral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:7456470","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7456470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wiener medizinische Wochenschrift (1946)","raw_type":"English Abstract"},{"id":"mag:2423919700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7456470","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2020682977","https://openalex.org/W2062293869","https://openalex.org/W2048804824","https://openalex.org/W2005957877","https://openalex.org/W2050400521","https://openalex.org/W1995937620","https://openalex.org/W2060777550","https://openalex.org/W2096756327","https://openalex.org/W7095432016","https://openalex.org/W2336499231"],"abstract_inverted_index":{"An":[0],"efficient":[1],"treatment":[2,125],"with":[3,126,130,143,164],"psycho-drugs":[4],"is":[5,21,62,139],"essential":[6],"for":[7,51],"the":[8,16,19,25,28,31,38,44,52,55,58,68,79,107,121,131,134,152,166,172],"initial":[9,33,173],"therapy":[10],"of":[11,18,30,54,86,99,102,124,133,151,161],"acute":[12],"schizophrenic":[13],"psychoses.":[14],"Also":[15],"outcome":[17],"psychosis":[20],"largely":[22],"dependent":[23],"on":[24,120],"influence":[26],"and":[27],"duration":[29],"existing":[32],"symptoms.":[34],"Neuroleptic":[35],"drugs":[36],"raise":[37],"plasma":[39,69,75,114,135],"prolactin":[40,70,76,115,136,167],"level":[41,109,116,168],"by":[42],"blocking":[43],"dopamine":[45],"receptors.":[46],"So":[47],"a":[48,118,158],"valid":[49],"parameter":[50],"interference":[53],"neuroleptics":[56],"in":[57,82],"dopaminergic":[59],"transmitter":[60],"system":[61],"available.":[63],"In":[64,157],"21":[65],"male":[66],"patients":[67,162],"levels":[71],"were":[72,78],"examined.":[73],"The":[74,113],"base-lines":[77],"same":[80],"as":[81],"healthy":[83],"persons.":[84],"Infusions":[85],"20":[87],"to":[88,96,106,171],"40":[89],"mg":[90],"fluphenazine":[91,127,146],"every":[92],"three":[93],"hours":[94],"led":[95],"an":[97,149],"average":[98],"fourfold":[100],"increase":[101],"prolactin,":[103],"which":[104,138],"returned":[105,170],"original":[108],"after":[110,176],"10":[111],"hours.":[112],"reached":[117,140],"plateau":[119],"7th":[122],"day":[123],"dihydrochloride.":[128],"Together":[129],"stabilisation":[132],"level,":[137],"more":[141],"quickly":[142],"simultaneously":[144],"administered":[145],"decanoate,":[147],"generally":[148],"improvement":[150],"psychopathological":[153],"condition":[154],"takes":[155],"place.":[156],"comparable":[159],"group":[160],"treated":[163],"ECT":[165],"always":[169],"point":[174],"even":[175],"multiple":[177],"administrations.":[178]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}